Patents by Inventor Thomas E. Scammell

Thomas E. Scammell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOMARKERS OF NEUROPATHIC PAIN
    Publication number: 20210386365
    Abstract: This disclosure is related to methods of objectively detecting and measuring neuropathic pain in a subject.
    Type: Application
    Filed: June 13, 2019
    Publication date: December 16, 2021
    Inventors: Clifford J. Woolf, Alban A. Latremoliere, Thomas E. Scammell, Chloe M. Alexandre
  • Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
    Patent number: 7087647
    Abstract: Modafinil is effective in improving symptoms of attention deficit hyperactivity disorder and symptoms of multiple sclerosis fatigue. The administration of modafinil is also shown to activate the tuberomamillary neurons of the posterior hypothalamus, and thus exhibits activity in an area of the brain associated with normal wakefulness functions.
    Type: Grant
    Filed: October 30, 2002
    Date of Patent: August 8, 2006
    Assignee: Cephalon, Inc.
    Inventors: Matthew S. Miller, Thomas E. Scammell
  • Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
    Publication number: 20030069313
    Abstract: Modafinil is effective in improving symptoms of attention deficit hyperactivity disorder and symptoms of multiple sclerosis fatigue. The administration of modafinil is also shown to activate the tuberomamillary neurons of the posterior hypothalamus, and thus exhibits activity in an area of the brain associated with normal wakefulness functions.
    Type: Application
    Filed: October 30, 2002
    Publication date: April 10, 2003
    Applicant: Cephalon, Inc.
    Inventors: Matthew S. Miller, Thomas E. Scammell
  • Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
    Patent number: 6488164
    Abstract: Modafinil is effective in improving symptoms of attention deficit hyperactivity disorder and symptoms of multiple sclerosis fatigue. The administration of modafinil is also shown to activate the tuberomamillary neurons of the posterior hypothalamus, and thus exhibits activity in an area of the brain associated with normal wakefulness functions.
    Type: Grant
    Filed: December 20, 2001
    Date of Patent: December 3, 2002
    Assignee: Cephalon, Inc.
    Inventors: Matthew S. Miller, Thomas E. Scammell
  • Compositions including modafinil for treatment of eating disorders and for appetite stimulation
    Patent number: 6455588
    Abstract: Modafinil is effective in improving symptoms of eating disorders or in stimulating appetite.
    Type: Grant
    Filed: August 17, 2000
    Date of Patent: September 24, 2002
    Assignee: Cephalon, Inc.
    Inventors: Thomas E. Scammell, Matthew S. Miller
  • Compositions including modafinil for treatment of eating disorders and for appetite stimulation
    Publication number: 20020128322
    Abstract: Modafinil is effective in improving symptoms of eating disorders or in stimulating appetite.
    Type: Application
    Filed: May 2, 2002
    Publication date: September 12, 2002
    Inventors: Thomas E. Scammell, Matthew S. Miller
  • Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
    Publication number: 20020082301
    Abstract: Modafinil is effective in improving symptoms of attention deficit hyperactivity disorder and symptoms of multiple sclerosis fatigue. The administration of modafinil is also shown to activate the tuberomamillary neurons of the posterior hypothalamus, and thus exhibits activity in an area of the brain associated with normal wakefulness functions.
    Type: Application
    Filed: December 20, 2001
    Publication date: June 27, 2002
    Applicant: Cephalon, Inc.
    Inventors: Matthew S. Miller, Thomas E. Scammell
  • Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
    Patent number: 6346548
    Abstract: Modafinil is effective in improving symptoms of attention deficit hyperactivity disorder and symptoms of multiple sclerosis fatigue. The administration of modafinil is also shown to activate the tuberomamillary neurons of the posterior hypothalamus, and thus exhibits activity in an area of the brain associated with normal wakefulness functions.
    Type: Grant
    Filed: August 15, 2000
    Date of Patent: February 12, 2002
    Assignee: Cephalon, Inc.
    Inventors: Matthew S. Miller, Thomas E. Scammell